Skip to content

Does SVT Get Better with Age? Understanding Supraventricular Tachycardia's Course

4 min read

Affecting as many as 1 in 1,000 healthy children, supraventricular tachycardia (SVT) is a common heart rhythm disorder. While some infants with the condition may see it resolve on its own by age one, the question of, "Does SVT get better with age?" has a more complex and often less positive answer for those diagnosed later in life. For most adults, episodes tend to become more frequent as they get older.

Quick Summary

Most people do not see SVT improve with age; in fact, episodes often become more frequent over time, though infants may outgrow the condition.

Key Points

  • SVT in Infants: Some babies with SVT outgrow the condition by age one, though recurrence is possible later in life.

  • SVT in Adults: For those diagnosed after infancy, SVT episodes generally tend to become more frequent as they get older.

  • Aging Heart Factors: Age-related changes like increased fibrosis in the heart's electrical system can contribute to the persistence or worsening of SVT.

  • Effective Treatments Exist: Catheter ablation is a highly successful and often permanent cure for many types of SVT.

  • Prognosis: While generally not life-threatening for those with otherwise healthy hearts, frequent or untreated SVT can lead to complications, especially with other heart conditions.

In This Article

How Age Impacts the Natural Course of SVT

The trajectory of supraventricular tachycardia can vary significantly based on when it first appears. The condition often arises from congenital electrical abnormalities, but the timing of symptom onset and frequency is not uniform across all age groups. For many, the condition is present from birth, but it may not become symptomatic until later in life, and its behavior can change with advancing age.

SVT in Infants and Young Children

SVT is the most common arrhythmia in the pediatric population. A distinct pattern is seen in babies who are diagnosed with the condition early on. Research indicates that many infants with SVT, especially those with Wolff-Parkinson-White (WPW) syndrome, will outgrow the arrhythmia by their first birthday. However, this spontaneous resolution is not a permanent guarantee. Up to 50% of children whose SVT resolves in infancy will experience a recurrence later in childhood or adolescence.

SVT in Adolescents and Adults

If SVT symptoms begin after infancy, the likelihood of the condition resolving on its own is low. Many individuals first experience SVT episodes during their teenage years or early adulthood, and the condition often persists for life. The frequency of these episodes can vary, with some patients experiencing them daily and others only every few years. There is a noted tendency for SVT episodes to become more frequent as an individual gets older, particularly with the onset of other age-related changes and conditions.

Comparison of SVT Across Age Groups

Aspect Infants (<1-2 years) Older Children/Adolescents Adults
Likelihood of Spontaneous Resolution High; often resolves by age 1. Low; recurrence common if resolved in infancy. Very low; episodes tend to increase in frequency.
Typical Triggers Often subtle; may occur without obvious triggers. Exercise, stress, stimulants, caffeine. Stress, alcohol, caffeine, other cardiac conditions.
Common Presentation Poor feeding, irritability, rapid breathing. Palpitations, dizziness, chest pain. Palpitations, anxiety, shortness of breath, chest pain.
Treatment Focus Observation, vagal maneuvers, medication (often temporarily). Lifestyle changes, medication, catheter ablation (often curative). Management of comorbidities, lifestyle changes, medication, ablation.
Typical Prognosis Generally benign with excellent outcomes. Benign with excellent outcomes, especially with ablation. Benign in otherwise healthy individuals, but risk of complications rises with other heart disease.

Why SVT Often Worsens with Age

For the majority of people, SVT is not a condition that improves naturally with age. Several physiological changes and comorbidities contribute to the tendency for episodes to become more frequent or symptomatic over time.

Degenerative Changes in the Heart

As the heart ages, it undergoes progressive degenerative changes, including fibrosis (the thickening and scarring of heart tissue). This can affect the sinoatrial (SA) node and the heart's overall conduction system, creating a less stable electrical environment. This tissue remodeling can create new pathways for re-entrant tachycardia or make existing ones more prone to triggering an SVT episode.

Increased Cardiac Comorbidities

With advancing age, the risk for other heart conditions increases, and these can exacerbate SVT. Conditions such as coronary artery disease, heart failure, and high blood pressure put added stress on the heart's electrical system. For example, the presence of heart disease can alter the heart's structure and electrical properties, making it more vulnerable to arrhythmias. This is distinct from the most common congenital causes of SVT in younger, otherwise healthy individuals.

Lifestyle and External Factors

Over a person's lifetime, exposure to various triggers can increase. These include chronic stress, which releases adrenaline that can overstimulate the heart, and cumulative use of substances like excessive caffeine and alcohol. Certain medications, including those for asthma and over-the-counter cold remedies containing stimulants, can also trigger SVT episodes. Managing these external factors becomes an important part of managing SVT, particularly as episodes become more frequent with age.

What is the Long-Term Prognosis for SVT?

Despite the potential for increasing frequency, the long-term prognosis for SVT is generally excellent, especially in individuals with otherwise healthy hearts. SVT is usually not life-threatening. The main issues arise from the unpredictability and discomfort of episodes, which can significantly impact a person's quality of life. However, for those with existing heart damage or other cardiac conditions, frequent or prolonged episodes can potentially lead to complications like heart failure. Fortunately, modern treatments offer a positive outlook.

Management and Treatment Options

An SVT diagnosis does not mean a life controlled by arrhythmia. Numerous strategies are available to manage and, in many cases, cure the condition.

Lifestyle Modifications

  • Identify and Avoid Triggers: Pay attention to what precedes an SVT episode. Many find that reducing or eliminating caffeine, alcohol, and stress can decrease frequency. Keeping a log of episodes can help identify personal triggers.
  • Vagal Maneuvers: For some, techniques like bearing down (Valsalva maneuver), coughing, or plunging the face into cold water can help interrupt an episode.
  • Heart-Healthy Habits: Regular exercise, a balanced diet, and staying hydrated are foundational for good cardiovascular health.

Medication

  • Rate and Rhythm Control: Medications such as beta-blockers and calcium channel blockers are often used to manage symptoms by slowing the heart rate. Antiarrhythmic drugs may also be prescribed, though they do not provide a permanent cure.

Catheter Ablation

  • A Curative Procedure: For those with frequent or symptomatic SVT, catheter ablation offers a highly effective and often permanent cure. During this minimally invasive procedure, a cardiologist uses targeted energy (heating or freezing) to destroy the small area of heart tissue causing the electrical short circuit. Success rates are high, typically ranging from 95-98%.

Conclusion

While some infants may outgrow SVT, the condition generally does not get better with age for older children and adults. Episodes often become more frequent over time due to a combination of age-related physiological changes in the heart and the presence of other cardiac conditions. The good news is that SVT is rarely life-threatening in otherwise healthy individuals and is highly treatable. With proper management, including lifestyle modifications, medication, and the curative option of catheter ablation, patients can effectively manage their symptoms and maintain an excellent quality of life.

Outbound Link: Learn more about heart arrhythmias from the American Heart Association

Frequently Asked Questions

Yes, in some infants, SVT can resolve spontaneously by their first birthday. However, if SVT persists beyond infancy, it is unlikely to go away on its own, and in most cases, episodes tend to increase in frequency with age.

Yes, older adults with SVT often have more frequent episodes and may face a higher risk of complications due to coexisting heart conditions, like heart disease or heart failure, which become more common with age.

For many patients, yes. Catheter ablation is a procedure that can permanently eliminate the underlying electrical short circuit causing SVT. It boasts a high success rate, often between 95-98%.

Yes, adopting a heart-healthy lifestyle and avoiding common triggers can help. Limiting caffeine, alcohol, and stress, along with regular exercise and staying hydrated, are effective management strategies for many individuals with SVT.

As people age, their hearts undergo structural changes, including fibrosis and remodeling, which can alter the heart's electrical pathways. The development of other comorbidities, such as heart disease, also adds strain that can trigger more frequent episodes.

Yes, certain medications can act as triggers. These can include over-the-counter cold and allergy medicines, decongestants, and asthma inhalers that contain stimulants.

While SVT is generally benign, frequent or prolonged episodes can weaken the heart muscle over time, potentially leading to heart failure, especially in individuals with other heart conditions. In rare cases, a severe episode can cause fainting or sudden cardiac arrest.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.